Venture Investments

Supporting Companies to Transform the Lives of Patients

Founded in 1996, Alexandria Venture Investments is the company's strategic venture capital arm. Alexandria Venture Investments provides long-term strategic investment capital to innovative life science and technology entities developing breakthrough technologies and therapies. 

Leveraging our experience and in-depth understanding of the life science and technology industries, our long-term relationships with leading investors, and our world-class scientific advisory network, we are uniquely positioned to fund seed-, early-, and growth-stage companies.

Read more in a recent press release.


Areas of Focus

  • Biopharma
  • Diagnostics
  • Research Tools
  • AgTech
  • Technology





Track Record

  • Most Active Biopharma Investor by new deal volume in 2017-2018, as recognized by Silicon Valley Bank
  • #1 venture capital investor in the healthcare sector by U.S.-based deal volume in 2018, as recognized by Forbes
  • $892M Book Value (as of December 31, 2018)
  • 140+ Direct Private Investments
  • 45+ IPO Exits between 2013 and 2018
  • 10+ M&A Exits between 2013 and 2018